Metagenomi Current Cash

The latest current cash for MGX is $39M as of June 2026. That compares with $27M in the prior-year period — up 45.4% year over year. Investors often review this figure alongside Metagenomi's historical trend and sector peers before judging valuation or financial health.

Over the past year, MGX's current cash moved from $27M to $39M — a 45.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Metagenomi's operating scale or balance-sheet position.

A current cash figure of $39M for MGX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MGX's current cash ($39M), review year-over-year change from $27M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.